KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Teladoc Health (TDOC) Operating Income (2016 - 2026)

Teladoc Health's Operating Income history spans 13 years, with the latest figure at -$61.8 million for Q1 2026.

  • On a quarterly basis, Operating Income rose 48.79% to -$61.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$204.1 million, a 80.64% increase, with the full-year FY2025 number at -$263.0 million, up 74.24% from a year prior.
  • Operating Income hit -$61.8 million in Q1 2026 for Teladoc Health, down from -$36.0 million in the prior quarter.
  • Over the last five years, Operating Income for TDOC hit a ceiling of -$35.1 million in Q4 2023 and a floor of -$6.7 billion in Q1 2022.
  • Historically, Operating Income has averaged -$896.9 million across 5 years, with a median of -$71.6 million in 2023.
  • Biggest five-year swings in Operating Income: plummeted 9109.86% in 2022 and later soared 99.08% in 2023.
  • Tracing TDOC's Operating Income over 5 years: stood at -$3.8 billion in 2022, then soared by 99.08% to -$35.1 million in 2023, then plummeted by 37.44% to -$48.2 million in 2024, then grew by 25.34% to -$36.0 million in 2025, then plummeted by 71.59% to -$61.8 million in 2026.
  • Business Quant data shows Operating Income for TDOC at -$61.8 million in Q1 2026, -$36.0 million in Q4 2025, and -$52.0 million in Q3 2025.